Abstract:OBJECTIVE: To investigate the effect of iASPP-full length(iASPP-FL) and iASPP-splice variant(iASPP-SV) on apoptosis and the genomic instability.METHODS: MCF-7 cell line was transfected with iASPP-FL and iASPP-SV plasmid,and cell lines that stably expressing iASPP-FL and iASPP-SV were identified.Flow cytometry was used to detect the cell apoptosis with DNA damage caused by radiation or etoposide(Vp-16).By alkaline single cell gel electrophoresis(comet assay) and Western Blot,we observed the existence of DNA double strand break damage and the difference between these cell lines.RESULTS: After 200 μg/mL Vp-16 treated,SV1 and SV2 cell lines that stably expressing iASPP-SV showed significantly decreasing early apoptosis rate from(42.70±2.38)% to(24.40±1.12)% and(17.52±1.08)%,and late apoptosis rate from(28.94±1.38)% to(18.78±0.95)% and(19.58±1.04)% compared with the cell line transfected with empty vector,while the expression of H2AX increased to 1.48 and 2.10 folds.FL1 and FL2 cell lines that stably expressing iASPP-FL showed significant reduction of early apoptosis rate from(31.22±1.64)% to(14.22±0.68)% and(15.82±0.74)%,and late apoptosis rate from(36.90±2.08)% to(11.16±0.88)% and(9.88±0.56)% compared with the cell line transfected with empty vector,while the expression of H2AX increased to 2.09 and 1.99 folds.After 4 Gy 137Cs iradiation,the early apoptosis rate of SV1 and FL1 decreased to(6.42±0.24)% and(7.05±0.24)% compared with the(16.56±0.81)% of empty vector group.The late apoptosis rate decreased to(15.10±0.50)% and(15.14±0.58)% compared with the(29.08±1.55)% of empty vector.Comet assay also showedmore DNA damages in iASPP-FL-or iASPP-SV-expressing cell lines than that in control cell line.CONCLUSION: iAPSS-FL/iASPP-SV an reduce apoptosis induced by radiation or Vp-16,with DNA damage accumulating which may promote the genomic instability and pathogenesis and/or progression of cancer.

iASPP-SV, an Important iASPP isoform, participated in breast tumorigenesis/progression

Identification of a Novel Isoform of Iaspp and Its Interaction with P53

Iasppsv Antagonizes Apoptosis Induced by Chemotherapeutic Agents in MCF-7 Cells and Mouse Thymocytes

Iaspp is Over-Expressed in Human Non-Small Cell Lung Cancer and Regulates the Proliferation of Lung Cancer Cells Through a P53 Associated Pathway

Overexpression of Iaspp-Sv in Glioma is Associated with Poor Prognosis by Promoting Cell Viability and Antagonizing Apoptosis.

iASPP is essential for HIF-1α stabilization to promote angiogenesis and glycolysis via attenuating VHL-mediated protein degradation

High iASPP (PPP1R13L) expression is an independent predictor of adverse clinical outcome in acute myeloid leukemia (AML)

Oncogene Iaspp Enhances Self‐renewal of Hematopoietic Stem Cells and Facilitates Their Resistance to Chemotherapy and Irradiation

GASP1 enhances malignant phenotypes of breast cancer cells and decreases their response to paclitaxel by forming a vicious cycle with IGF1/IGF1R signaling pathway

Effect of Iaspp on the Anti-Apoptosis and Genomic Instability of MCF-7

XIAP Facilitates Breast and Colon Carcinoma Growth Via Promotion of P62 Depletion Through Ubiquitination-Dependent Proteasomal Degradation

Reactivating p53 functions by suppressing its novel inhibitor iASPP: a potential therapeutic opportunity in p53 wild-type tumors

The expression of iASPP in acute leukemias.

siRNA-mediated down-regulation of iASPP promotes apoptosis induced by etoposide and daunorubicin in leukemia cells expressing wild-type p53.

Iaspp Overexpression is Associated with Clinical Outcome in Spinal Chordoma and Influences Cellular Proliferation, Invasion, and Sensitivity to Cisplatin in Vitro.

An Alternatively Spliced P62 Isoform Confers Resistance to Chemotherapy in Breast Cancer

Iaspp Facilitates Tumor Growth by Promoting Mtor-Dependent Autophagy in Human Non-Small-cell Lung Cancer.

Sertad1 Antagonizes Iaspp Function by Hindering Its Entrance into Nuclei to Interact with P53 in Leukemic Cells

iASPP protects the heart from ischemia injury by inhibiting p53 expression and cardiomyocyte apoptosis

Secreted Phosphoprotein 1 As a Potential Prognostic and Immunotherapy Biomarker in Multiple Human Cancers

ASPP1/2 positive patients with invasive breast cancers have good prognosis